EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unraveling Differences in Molecular Mechanisms and Immunological Contrasts between Squamous Cell Carcinoma and Adenocarcinoma of the Cervix

Morteza Salarzaei, Ralf L O van de Laar iD, Patricia C Ewing-Graham iD, Shiva Najjary, Edith van Esch, Heleen J van Beekhuizen iD, Dana A M Mustafa iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25116205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Morteza Salarzaei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecologic Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Carcinoma, Squamous Cell, Adenocarcinoma, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hoyerik, Erasmus Trustfonds (specifically the Hoijerik fund).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to refine our understanding of the inherent heterogeneity in cervical cancer by exploring differential gene expression profiles, immune cell infiltration dynamics, and implicated signaling pathways in the two predominant histological types of cervix carcinoma, Squamous Cell Carcinoma (SCC) and Adenocarcinoma (ADC). Targeted gene expression data that were previously generated from samples of primary cervical cancer were re-analyzed. The samples were grouped based on their histopathology, comparing SCC to ADC. Each tumor in the study was confirmed to be high risk human papilloma virus (hrHPV) positive. A total of 21 cervical cancer samples were included, with 11 cases of SCC and 10 of ADC. Data analysis revealed a total of 26 differentially expressed genes, with 19 genes being overexpressed in SCC compared to ADC (Benjamini–Hochberg (BH)-adjusted p-value < 0.05). Importantly, the immune checkpoint markers CD274 and CTLA4 demonstrated significantly higher expression in SCC compared to ADC. In addition, SCC showed a higher infiltration of immune cells, including B and T cells, and cytotoxic cells. Higher activation of a variety of pathways was found in SCC samples including cytotoxicity, interferon signaling, metabolic stress, lymphoid compartment, hypoxia, PI3k-AKT, hedgehog signaling and Notch signaling pathways. Our findings show distinctive gene expression patterns, signaling pathway activations, and trends in immune cell infiltration between SCC and ADC in cervical cancer. This study underscores the heterogeneity within primary cervical cancer, emphasizing the potential benefits of subdividing these tumours based on histological and molecular differences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsCarcinoma, Squamous CellAdenocarcinomaGene Expression Regulation, NeoplasticHumansFemaleSignal TransductionBiomarkers, TumorCTLA-4 AntigenGene Expression ProfilingB7-H1 AntigenMiddle AgedTranscriptomePapillomavirus Infections

Stichwörter der Autor:innen

adenocarcinomacervical cancerimmune cellssquamous cell carcinomatargeted gene expression profiling

Substanzen

Biomarkers, TumorCTLA-4 AntigenB7-H1 AntigenCD274 protein, humanCTLA4 protein, human

Autor:innen und Institutionen

  • Department of Gynaecologic Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
  • Department of Pathology and Clinical Bioinformatics, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
  • Department of Pathology and Clinical Bioinformatics, The Tumor Immuno-Pathology Laboratory, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
  • Department of Gynecology and Obstetrics, Catharina Ziekenhuis Eindhoven, Michelangelolaan 2, 5623 EJ Eindhoven, The Netherlands.

ORCID-Profile: Ralf L O van de Laar, Patricia C Ewing-Graham, Heleen J van Beekhuizen, Dana A M Mustafa

Förderung

  • Hoyerik
  • Erasmus Trustfonds (specifically the Hoijerik fund)

Zitieren

APA

Salarzaei, M., van de Laar, R. L. O., Ewing-Graham, P. C., Najjary, S., van Esch, E., van Beekhuizen, H. J., & Mustafa, D. A. M. (2024). Unraveling Differences in Molecular Mechanisms and Immunological Contrasts between Squamous Cell Carcinoma and Adenocarcinoma of the Cervix. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25116205

Vancouver

Salarzaei M, van de Laar RLO, Ewing-Graham PC, Najjary S, van Esch E, van Beekhuizen HJ, et al. Unraveling Differences in Molecular Mechanisms and Immunological Contrasts between Squamous Cell Carcinoma and Adenocarcinoma of the Cervix. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25116205

BibTeX
@article{Salarzaei2024,
  author = {Salarzaei, Morteza and van de Laar, Ralf L O and Ewing-Graham, Patricia C and Najjary, Shiva and van Esch, Edith and van Beekhuizen, Heleen J and Mustafa, Dana A M},
  title = {Unraveling Differences in Molecular Mechanisms and Immunological Contrasts between Squamous Cell Carcinoma and Adenocarcinoma of the Cervix},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25116205}
}
Kostenlos starten →